Search Page

1

Cite

Share

NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors.

Wang-Gillam A, Hubner RA, Siveke JT, Von Hoff DD, Belanger B, de Jong FA, Mirakhur B, Chen LT. Wang-Gillam A, et al. Among authors: mirakhur b. Eur J Cancer. 2019 Feb;108:78-87. doi: 10.1016/j.ejca.2018.12.007. Epub 2019 Jan 14. Eur J Cancer. 2019. PMID: 30654298 Free article. Clinical Trial.

Cite

Share

2

Cite

Share

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial.

Hauschild A, Grob JJ, Demidov LV, Jouary T, Gutzmer R, Millward M, Rutkowski P, Blank CU, Miller WH Jr, Kaempgen E, Martín-Algarra S, Karaszewska B, Mauch C, Chiarion-Sileni V, Martin AM, Swann S, Haney P, Mirakhur B, Guckert ME, Goodman V, Chapman PB. Hauschild A, et al. Among authors: mirakhur b. Lancet. 2012 Jul 28;380(9839):358-65. doi: 10.1016/S0140-6736(12)60868-X. Epub 2012 Jun 25. Lancet. 2012. PMID: 22735384 Clinical Trial.

Cite

Share

3

Cite

Share

Novel Tumor Growth Rate Analysis in the Randomized CLARINET Study Establishes the Efficacy of Lanreotide Depot/Autogel 120 mg with Prolonged Administration in Indolent Neuroendocrine Tumors.

Dromain C, Loaiza-Bonilla A, Mirakhur B, Beveridge TJR, Fojo AT. Dromain C, et al. Among authors: mirakhur b. Oncologist. 2021 Apr;26(4):e632-e638. doi: 10.1002/onco.13669. Epub 2021 Feb 1. Oncologist. 2021. PMID: 33393112 Free PMC article.

Cite

Share

4

Cite

Share

Medical record review of transition to lanreotide following octreotide for neuroendocrine tumors.

Saif MW, Parikh R, Ray D, Kaye JA, Kurosky SK, Thomas K, Ramirez RA, Halfdanarson TR, Beveridge TJR, Mirakhur B, Nagar SP, Soares HP. Saif MW, et al. Among authors: mirakhur b. J Gastrointest Oncol. 2019 Aug;10(4):674-687. doi: 10.21037/jgo.2019.03.11. J Gastrointest Oncol. 2019. PMID: 31392048 Free PMC article.

Cite

Share

5

Cite

Share

Early dose reduction/delay and the efficacy of liposomal irinotecan with fluorouracil and leucovorin in metastatic pancreatic ductal adenocarcinoma (mPDAC): A post hoc analysis of NAPOLI-1.

Chen LT, Macarulla T, Blanc JF, Mirakhur B, de Jong FA, Belanger B, Bekaii-Saab T, Siveke JT. Chen LT, et al. Among authors: mirakhur b. Pancreatology. 2021 Jan;21(1):192-199. doi: 10.1016/j.pan.2020.10.029. Epub 2020 Oct 10. Pancreatology. 2021. PMID: 33214082 Free article. Clinical Trial.

Cite

Share

6

Cite

Share

Treatment Outcomes in Patients with Metastatic Neuroendocrine Tumors: a Retrospective Analysis of a Community Oncology Database.

Fisher MD, Pulgar S, Kulke MH, Mirakhur B, Miller PJ, Walker MS, Schwartzberg LS. Fisher MD, et al. Among authors: mirakhur b. J Gastrointest Cancer. 2019 Dec;50(4):816-823. doi: 10.1007/s12029-018-0160-x. J Gastrointest Cancer. 2019. PMID: 30121904 Free PMC article.

Cite

Share

7

Cite

Share

Screening for comorbid conditions in patients enrolled in the SODA registry: a 2-year observational analysis.

Woodmansee WW, Gordon MB, Molitch ME, Ioachimescu AG, Carver DW, Mirakhur B, Cox D, Salvatori R. Woodmansee WW, et al. Among authors: mirakhur b. Endocrine. 2018 Jul;61(1):105-117. doi: 10.1007/s12020-018-1615-3. Epub 2018 May 16. Endocrine. 2018. PMID: 29767287 Free PMC article.

Cite

Share

8

Cite

Share

Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors.

Pavel ME, Phan AT, Wolin EM, Mirakhur B, Liyanage N, Pitman Lowenthal S, Fisher GA Jr, Vinik AI; CLARINET Study Investigators. Pavel ME, et al. Among authors: mirakhur b. Oncologist. 2019 Apr;24(4):463-474. doi: 10.1634/theoncologist.2018-0217. Epub 2018 Oct 24. Oncologist. 2019. PMID: 30355775 Free PMC article. Clinical Trial.

Cite

Share

9

Cite

Share

Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose.

Chung CH, Mirakhur B, Chan E, Le QT, Berlin J, Morse M, Murphy BA, Satinover SM, Hosen J, Mauro D, Slebos RJ, Zhou Q, Gold D, Hatley T, Hicklin DJ, Platts-Mills TA. Chung CH, et al. Among authors: mirakhur b. N Engl J Med. 2008 Mar 13;358(11):1109-17. doi: 10.1056/NEJMoa074943. N Engl J Med. 2008. PMID: 18337601 Free PMC article.

Cite

Share

10

Cite

Share

Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer - A subgroup analysis of the pivotal NAPOLI-1 trial.

Macarulla T, Blanc JF, Wang-Gillam A, Chen LT, Siveke JT, Mirakhur B, Chen J, de Jong FA. Macarulla T, et al. Among authors: mirakhur b. J Geriatr Oncol. 2019 May;10(3):427-435. doi: 10.1016/j.jgo.2019.02.011. Epub 2019 Mar 4. J Geriatr Oncol. 2019. PMID: 30842038 Free article. Clinical Trial.

Cite

Share